手机验证
/
VERO; VeroCCL81; Vero 81; Verda reno
/
充足
/
/
/
/
/
点击咨询
非洲绿猴肾细胞
其它
/
上皮样
/
电话咨询
复苏发货或干冰冷冻发货
/
贴壁
1 x 10^6 cells/vial/T25
细胞名称:Vero非洲绿猴肾细胞
产品货号:C3039
培养条件:DMEM+10%FBS+1%PS(货号:M0101)
生长特性:贴壁
细胞形态:上皮样
产品规格:1 x 10^6 cells/vial/T25
产品货号 | 细胞名称 | 中文名称 | 生长特性 | 细胞形态 | 产品规格 |
C3001 | PC-12 | 大鼠肾上腺嗜铬细胞瘤细 胞(高分化) | 贴壁 | 多角形 | 1 x 10^6 cells/vial/T25 |
C3007 | NRK-52E | 大鼠肾细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C3008 | PC-12 | 大鼠肾上腺嗜铬细胞瘤细 胞(低分化) | 贴壁 | 多角形 | 1 x 10^6 cells/vial/T25 |
C3009 | F81 | 猫肾细胞 | 贴壁 | 内皮样 | 1 x 10^6 cells/vial/T25 |
C3012 | Marc145 | 长尾绿猴肾上皮细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C3014 | BHK-21 [C-13] | 仓鼠肾成纤维细胞 | 贴壁 | 成纤维细胞 | 1 x 10^6 cells/vial/T25 |
C3016 | COS-7 | 非洲绿猴SV40转化的肾细 胞 | 贴壁 | 成纤维细胞 | 1 x 10^6 cells/vial/T25 |
C3017 | LLC-MK2 | 恒河猴肾细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C3019 | COS-1 | 非洲绿猴SV40转化的肾细 胞 | 贴壁 | 成纤维细胞 | 1 x 10^6 cells/vial/T25 |
C3024 | MA104 | 罗猴胎肾细胞系 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
C3032 | MDCK(NBL-2) | 狗肾细胞 | 贴壁 | 上皮样 | 1 x 10^6 cells/vial/T25 |
细胞在发货前进行质检:
1、细胞存种的活性检测;
2、细菌、真菌、霉菌污染物镜检;
3、衣原体、支原体检测。
联系人:胡经理
电话:15921028707(微信同号)
:3407506161
:021-55150076
官网:https://whelab.com
公司邮箱:info@whelab.com
技术邮箱:tech@whelab.com
地址:上海宝山区呼兰西路129号8号楼4层
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
CLPUB00126
Yasumura Y., Kawakita Y.
Studies on SV40 in tissue culture: preliminary step for cancer research in vitro.
Nihon Rinsho 21:1201-1219(1963)
PubMed=6027511; DOI=10.3181/00379727-125-32029
Simizu B., Rhim J.S., Wiebenga N.H.
Characterization of the Tacaribe group of arboviruses. I. Propagation and plaque assay of Tacaribe virus in a line of African green monkey kidney cells (Vero).
Proc. Soc. Exp. Biol. Med. 125:119-123(1967)
DOI=10.1007/BF02618370
Stulberg C.S., Coriell L.L., Kniazeff A.J., Shannon J.E.
The animal cell culture collection.
In Vitro 5:1-16(1970)
PubMed=6298990; DOI=10.1016/0378-1135(82)90056-6
McPhee D.A., Parsonson I.M., Della-Porta A.J.
Comparative studies on the growth of Australian bluetongue virus serotypes in continuous cell lines and embryonated chicken eggs.
Vet. Microbiol. 7:401-410(1982)
PubMed=4043530
Whitaker A.M., Hayward C.J.
The characterization of three monkey kidney cell lines.
Dev. Biol. Stand. 60:125-131(1985)
CLPUB00328
Earley E.M., Johnson K.M.
The lineage of Vero, Vero 76 and its clone C1008 in the United States.
(In) Vero cells: origin, properties and biomedical applications; Simizu B., Terasima T. (eds.); pp.26-29; Department of Microbiology School of Medicine Chiba University; Chiba (1988)
PubMed=2260226
Tsareva A.A., Isaenko A.A., Urmanova M.A., Yurchenko N.D., Balzovskaia E.G., Rodionova O.M.
A karyotype study of the Vero cell line cultured long term in a monolayer by static and roller methods.
Tsitologiia 32:741-748(1990)
PubMed=10403033; DOI=10.1006/biol.1998.0156
Lang J., Cetre J.C., Picot N., Lanta M., Briantais P., Vital S., Le Mener V., Lutsch C., Rotivel Y.
Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
Biologicals 26:299-308(1998)
PubMed=10494966
Montagnon B.J., Vincent-Falquet J.-C., Saluzzo J.-F.
Experience with Vero cells at Pasteur Merieux Connaught.
Dev. Biol. Stand. 98:137-140(1999)
PubMed=12667817; DOI=10.1016/S0042-6822(02)00064-8
Romanova J., Katinger D., Ferko B., Voglauer R., Mochalova L., Bovin N., Lim W., Katinger H., Egorov A.
Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern.
Virology 307:90-97(2003)
PubMed=16494729; DOI=10.3201/eid1201.050496
Kaye M., Druce J., Tran T., Kostecki R., Chibo D., Morris J., Catton M., Birch C.
SARS-associated coronavirus replication in cell lines.
Emerg. Infect. Dis. 12:128-133(2006)
DOI=10.12665/J63.Morgan
Morgan J.H.
Vero cells in vaccine production.
BioProcess. J. 6:12-17(2007)
PubMed=19016439; DOI=10.1002/9780471729259.mca04es11
Ammerman N.C., Beier-Sexton M., Azad A.F.
Growth and maintenance of Vero cell lines.
Curr. Protoc. Microbiol. 11:A.4E.1-A.4E.7(2008)
PubMed=19768803; DOI=10.1002/btpr.279
Rourou S., van der Ark A., van der Velden T., Kallel H.
Development of an animal-component free medium for Vero cells culture.
Biotechnol. Prog. 25:1752-1761(2009)
PubMed=19941903; DOI=10.1016/j.jviromet.2009.11.022
Karger A., Bettin B., Lenk M., Mettenleiter T.C.
Rapid characterisation of cell cultures by matrix-assisted laser desorption/ionisation mass spectrometric typing.
J. Virol. Methods 164:116-121(2010)
PubMed=22059503; DOI=10.1186/1472-6750-11-102
Almeida J.L., Hill C.R., Cole K.D.
Authentication of African green monkey cell lines using human short tandem repeat markers.
BMC Biotechnol. 11:102.1-102.10(2011)
PubMed=24975811; DOI=10.1016/j.vaccine.2014.06.045
Donis R.O., Chen L.-M., Davis C.T., Foust A., Hossain M.J., Johnson A., Klimov A., Loughlin R.F., Xu X.-Y., Tsai T., Blayer S., Trusheim H., Colegate T., Fox J., Taylor B., Hussain A.I., Barr I., Baas C., Louwerens J., Geuns E., Lee M.-S., Venhuizen L., Neumeier E., Ziegler T.
Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
Vaccine 32:6583-6590(2014)
PubMed=25267831; DOI=10.1093/dnares/dsu029
Osada N., Kohara A., Yamaji T., Hirayama N., Kasai F., Sekizuka T., Kuroda M., Hanada K.
The genome landscape of the African green monkey kidney-derived Vero cell line.
DNA Res. 21:673-683(2014)
PubMed=25903999; DOI=10.1002/biot.201400388
Genzel Y.
Designing cell lines for viral vaccine production: where do we stand?
Biotechnol. J. 10:728-740(2015)
PubMed=28386771; DOI=10.1007/s10616-017-0082-7
Andreani N.A., Renzi S., Piovani G., Ajmone-Marsan P., Bomba L., Villa R., Ferrari M., Dotti S.
Potential neoplastic evolution of Vero cells: in vivo and in vitro characterization.
Cytotechnology 69:741-750(2017)
PubMed=32376603; DOI=10.1126/science.abc1932
Gao Q., Bao L.-L., Mao H.-Y., Wang L., Xu K.-W., Yang M.-N., Li Y.-J., Zhu L., Wang N., Lv Z., Gao H., Ge X.-Q., Kan B., Hu Y.-L., Liu J.-N., Cai F., Jiang D.-Y., Yin Y.-H., Qin C.-F., Li J., Gong X.-J., Lou X.-Y., Shi W., Wu D.-D., Zhang H.-M., Zhu L., Deng W., Li Y.-R., Lu J.-X., Li C.-G., Wang X.-X., Yin W.-D., Zhang Y.-J., Qin C.
Development of an inactivated vaccine candidate for SARS-CoV-2.
Science 369:77-81(2020)
PubMed=32511316; DOI=10.1101/2020.03.02.972935
Harcourt J.L., Tamin A., Lu X.-Y., Kamili S., Kumar-Sakthivel S., Murray J., Queen K., Tao Y., Paden C.R., Zhang J., Li Y., Uehara A., Wang H.-B., Goldsmith C., Bullock H.A., Wang L.-J., Whitaker B., Lynch B., Gautam R., Schindewolf C., Lokugamage K.G., Scharton D., Plante J.A., Mirchandani D., Widen S.G., Narayanan K., Makino S., Ksiazek T.G., Plante K.S., Weaver S.C., Lindstrom S., Tong S.-X., Menachery V.D., Thornburg N.J.
Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient.
bioRxiv 2020:972935-972935(2020)
PubMed=33389257; DOI=10.1007/s10096-020-04106-0
Wurtz N., Penant G., Jardot P., Duclos N., La Scola B.
Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile.
Eur. J. Clin. Microbiol. Infect. Dis. 40:477-484(2021)
需要更多技术资料 索取更多技术资料
C3039-Vero.pdf 附 (下载 0 次)